AT297021B - Verfahren zur Herstellung neuer Xanthinverbindungen - Google Patents
Verfahren zur Herstellung neuer XanthinverbindungenInfo
- Publication number
- AT297021B AT297021B AT682270A AT682270A AT297021B AT 297021 B AT297021 B AT 297021B AT 682270 A AT682270 A AT 682270A AT 682270 A AT682270 A AT 682270A AT 297021 B AT297021 B AT 297021B
- Authority
- AT
- Austria
- Prior art keywords
- production
- xanthine compounds
- new xanthine
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/08—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/10—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
- C07D473/12—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1, 3, and 7, e.g. caffeine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US84626469A | 1969-07-30 | 1969-07-30 | |
US4559470A | 1970-06-11 | 1970-06-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
AT297021B true AT297021B (de) | 1972-03-10 |
Family
ID=26722972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT682270A AT297021B (de) | 1969-07-30 | 1970-07-27 | Verfahren zur Herstellung neuer Xanthinverbindungen |
Country Status (8)
Country | Link |
---|---|
AT (1) | AT297021B (de) |
BE (1) | BE754007A (de) |
CA (1) | CA929519A (de) |
CH (2) | CH512486A (de) |
DE (1) | DE2037171C3 (de) |
FR (1) | FR2059577B1 (de) |
GB (1) | GB1280424A (de) |
NL (1) | NL7011094A (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5484920A (en) * | 1992-04-08 | 1996-01-16 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic agent for Parkinson's disease |
CA2093403C (en) * | 1992-04-08 | 1999-08-10 | Fumio Suzuki | Therapeutic agent for parkinson's disease |
JP2613355B2 (ja) * | 1992-09-28 | 1997-05-28 | 協和醗酵工業株式会社 | パーキンソン氏病治療剤 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3317533A (en) * | 1967-05-02 | Theophylline derivatives |
-
1970
- 1970-07-27 DE DE19702037171 patent/DE2037171C3/de not_active Expired
- 1970-07-27 CH CH1134770A patent/CH512486A/fr not_active IP Right Cessation
- 1970-07-27 NL NL7011094A patent/NL7011094A/xx unknown
- 1970-07-27 FR FR7027624A patent/FR2059577B1/fr not_active Expired
- 1970-07-27 AT AT682270A patent/AT297021B/de not_active IP Right Cessation
- 1970-07-27 BE BE754007D patent/BE754007A/xx unknown
- 1970-07-27 GB GB3634870A patent/GB1280424A/en not_active Expired
- 1970-07-27 CA CA089226A patent/CA929519A/en not_active Expired
- 1970-07-27 CH CH1034971A patent/CH512487A/fr not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE2037171C3 (de) | 1978-05-18 |
FR2059577A1 (de) | 1971-06-04 |
CA929519A (en) | 1973-07-03 |
FR2059577B1 (de) | 1973-08-10 |
GB1280424A (en) | 1972-07-05 |
BE754007A (fr) | 1970-12-31 |
CH512487A (fr) | 1971-09-15 |
CH512486A (fr) | 1971-09-15 |
NL7011094A (de) | 1971-02-02 |
DE2037171A1 (de) | 1971-02-18 |
DE2037171B2 (de) | 1977-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH539012A (de) | Verfahren zur Herstellung neuer Phenoxyalkancarbonsäuren | |
AT311315B (de) | Verfahren zur Herstellung neuer Alkoxydinitroaniline | |
AT326674B (de) | Verfahren zur herstellung neuer naphthyridinderivaten | |
AT309696B (de) | Verfahren zur Herstellung neuer D-Arabinofuranosylpurinderivate | |
CH536803A (de) | Verfahren zur Herstellung neuer Naphthylpropionsäuren | |
CH508627A (de) | Verfahren zur Herstellung neuer Hexahydrobenzazocine | |
AT306256B (de) | Verfahren zur Herstellung neuer Benzomorphanderivate | |
CH537895A (de) | Verfahren zur Herstellung neuer Hydroxycrotonsäuren | |
AT303272B (de) | Verfahren zur Herstellung neuer Evomonosid-Derivate | |
CH535730A (de) | Verfahren zur Herstellung neuer Naphthylalkanole | |
CH530988A (de) | Verfahren zur Herstellung neuer Diallylaminoalkanoylamide | |
AT299916B (de) | Verfahren zur Herstellung neuer bis-Aminobenzoate | |
CH516591A (de) | Verfahren zur Herstellung neuer Thiazolopyrrolopyrimidine | |
AT305266B (de) | Verfahren zur Herstellung neuer substituierter 2-Benzylphenole | |
AT297021B (de) | Verfahren zur Herstellung neuer Xanthinverbindungen | |
AT295512B (de) | Verfahren zur Herstellung neuer Pyrrolderivate | |
AT301036B (de) | Verfahren zur Herstellung neuer Neriifolin-Derivate | |
CH498817A (de) | Verfahren zur Herstellung neuer Isothiocyanato-diphenylamine | |
AT319914B (de) | Verfahren zur Herstellung neuer Triazapentadiene | |
CH518973A (de) | Verfahren zur Herstellung neuer Furanonderivate | |
CH528492A (de) | Verfahren zur Herstellung neuer 18-Methyl-5a-H-androstane | |
AT299176B (de) | Verfahren zur Herstellung neuer Hexahydrophenanthrenderivate | |
CH497402A (de) | Verfahren zur Herstellung neuer Isothiocyanato-N-alkanoyl-diphenylamine | |
AT299941B (de) | Verfahren zur Herstellung neuer Thiazolderivate | |
CH515219A (de) | Verfahren zur Herstellung neuer Harnstoffe |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ELJ | Ceased due to non-payment of the annual fee |